Hillhouse Investment Group, established in 2005 and headquartered in Hong Kong, is a prominent global investment management firm that focuses on private equity. The firm engages in long-term investments across various sectors, including healthcare, business services, consumer goods, industrials, and energy transition. Hillhouse partners with exceptional entrepreneurs to foster sustainable value creation within quality companies. In addition to private equity, the firm also participates in public equity, real estate, and private credit, managing capital on behalf of global institutions such as non-profit foundations, endowments, and pension funds.
Sainte is a company which provides professional nutritional solutions for babies with different nutritional needs
ZJeagles Comsemi
Series B in 2025
ZJeagles Comsemi specializes in the design and production of optical communication chips tailored for data centers and various industrial applications. The company's product range includes high-speed optical communication VCSEL chips, high-power-density lidar VCSEL chips, and high-efficiency 3D sensing VCSEL chips. These advanced chips support critical functions in data center optical interconnection, automotive autonomous driving, and smart lighting. Additionally, ZJeagles Comsemi offers innovative LED packaging products that enhance the capabilities of consumer electronics and industrial systems. By providing comprehensive chip solutions, the company aims to empower its industry customers with essential production inputs for their technological advancements.
dinii
Series B in 2024
Dinii is a software company that specializes in creating digital ordering platforms tailored for restaurants and local take-out establishments. The company develops a mobile ordering platform that connects customers with dining options through their smartphones. Dinii's services enable restaurant businesses to streamline the online ordering process, allowing customers to easily select products, complete transactions, and receive printed invoices automatically. Additionally, the platform supports QR code ordering, enhancing the dining experience and improving operational efficiency for restaurants by increasing turnover and reducing overhead costs.
Silicon Box
Series B in 2024
Silicon Box is an advanced provider of outsourced semiconductor assembly and testing services, focusing on semiconductor integration. The company offers comprehensive capabilities in semiconductor packaging, from initial design to the final manufacturing of various chip types, including standard single chip packages and sophisticated chiplet-based systems. Its services support a wide range of applications, such as artificial intelligence, high-performance computing, electric vehicles, automotive technologies, power management, and mobile chipsets. Silicon Box aims to enhance chipset design through its manufacturing processes, which help shorten design cycles, reduce costs, and lower power consumption, ultimately delivering advanced and high-quality semiconductor interconnections to its customers.
Tenways
Series B in 2023
Tenways is a manufacturer and seller of eBikes designed to facilitate daily commuting in an effortless, speedy, and eco-friendly manner. The company focuses on creating affordable and easy-to-use bicycles that cater to a growing demand for sustainable transportation options. With a robust, vertically integrated global manufacturing and supply chain, Tenways ensures that its eBikes are not only reliable but also contribute to reducing the carbon footprint associated with traditional commuting methods.
SinceVision
Series C in 2023
SinceVision is a manufacturing company that provides high-speed cameras, 3D laser profilers, sensors, and technical support services.
TangFeng Energy
Series C in 2023
TangFeng Energy focuses on the research and development of fuel cell membrane electrodes that offer low cost, high performance, and exceptional durability. The company is involved in the entire process of these products, including research, development, production, testing, and sales. By providing innovative membrane electrode solutions, TangFeng Energy aims to meet the demands of clients seeking efficient and reliable fuel cell technologies.
ProBio
Series C in 2023
ProBio Inc. is a one-stop biopharmaceutical R&D and production platform. It provides end-to-end services for cell and gene therapy drugs, vaccine and biopharmaceutical discovery, antibody protein drugs.
Capcon
Series B in 2023
Capcon is a developer and manufacturer specializing in semiconductor assembly and packaging equipment. The company provides advanced products and innovative solutions tailored for the semiconductor assembly and packaging industry. Its diverse product line includes Flip-Chip Bonders, Chip-on-Wafer Bonders, Package-on-Package Bonders, Stack Die Bonders, Panel-Level Die Bonders, and Multi-Chip Die Bonders. These offerings enable clients to utilize high-precision, high-speed, and high-reliability semiconductor equipment, thereby enhancing productivity in their operations.
Hystar
Series B in 2023
Hystar is a company established in 2020 that specializes in the development of polymer electrolyte membrane electrolyzers intended for large-scale green hydrogen production. Its innovative technology features a distinctive cell design and process architecture that aims to lower electricity consumption while enhancing hydrogen output. This advancement supports professionals in addressing significant energy challenges and offers the potential to diminish greenhouse gas emissions.
Astronergy
Series B in 2023
Astronergy is a manufacturing firm that specializes in the research, development, and production of solar modules to generate clean energy. Established in 2006, it is recognized as the first large-scale producer of high-efficiency thin film photovoltaic (PV) modules in mainland China. The company is a trusted provider of both monocrystalline and polycrystalline PV modules and focuses on creating high-efficiency crystalline silicon solar cells and modules. These products are designed for various applications, including utility-scale power stations, commercial and industrial PV systems, and residential PV systems. Astronergy aims to deliver high-quality and high-performance photovoltaic solutions to support the global transition to renewable energy.
Core Medical Technology
Series C in 2022
Core Medical Technology is a technology enterprise mainly engaged in the research, production, development, and sales of implantable left ventricular assist devices, extracorporeal ventricular assist devices, percutaneous interventional ventricular assist devices, and equipment. The company was founded in 2016 and is based in Shenzhen, China.
ZCOOL
Series C in 2022
ZCOOL is an online community platform founded in August 2006 in Beijing, designed for designers to showcase their graphic designs and connect with potential commercial opportunities. With over four million users and approximately 20,000 design works uploaded daily, the platform facilitates the sharing and display of creative work. ZCOOL collaborates with Shutterstock to enhance its image database services, further enriching the offerings for its users. The company aims to leverage recent funding to expand its community, strengthen content, and provide additional services, including training courses and job matching to support its members in their professional development.
Zilliz
Series B in 2022
Zilliz is a prominent vector database company based in San Francisco, California, founded in 2016. It specializes in developing advanced data processing platforms that leverage artificial intelligence and big data technologies. Zilliz is known for Milvus, an open-source vector database designed to facilitate the creation of AI and machine learning applications. By simplifying complex data infrastructure management, the company aims to enable organizations to harness the advantages of AI for a variety of applications, including computer vision, natural language processing, recommendation systems, and more. Zilliz supports over 1,000 organizations globally, helping them unlock insights from unstructured data while improving query performance through GPU hardware acceleration. Its investor backing includes notable firms such as Hillhouse Capital and Temasek's Pavilion Capital, underscoring its position in the AI and data management sectors.
Jinjiang Electronic Technology
Series B in 2022
Jinjiang Electronic Technology is a med-tech company focused on the research and development as well as the manufacture of advanced medical equipment designed to enhance patient care in the field of cardiac electrophysiology. The company offers a range of innovative products, including a 3D cardiac mapping system, electrophysiology recording system, cardiac RF ablation generator, and irrigation pump. These devices provide comprehensive solutions aimed at diagnosing and treating arrhythmias, ultimately improving the quality of life for patients with heart conditions.
Proton Bio
Series B in 2022
Porton Advanced Solutions (Porton Advanced) is a CDMO specializing in Cell and Gene Therapy (CGT). To address clients' therapeutic product demands at the pre-clinical, clinical, and commercial stages, the firm offers end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services.
Maxvax Health
Series B in 2022
MAXVAX is focused on the development and commercialization of innovative vaccines, specifically targeting viral diseases such as rotavirus, shingles, and herpes. The company's technology is designed to enhance treatment options within the biotechnology industry, enabling healthcare professionals to offer improved solutions for patients suffering from these infections. By concentrating on effective vaccine development, MAXVAX aims to contribute significantly to the healthcare sector and improve patient outcomes.
Semitech
Series B in 2022
Semitech is an intelligent manufacturing system supplier focused on providing integrated manufacturing solutions for high-tech industries.
Style3D
Series B in 2022
Style3D is a software and service ecosystem for all fashion that enables designers and businesses to work on real-time 3D simulation outperforming their productivity and creativity while reaching higher sustainability.
Qingyun Zhitong
Series B in 2022
Qingyun Zhitong is an intelligent manufacturing enabling enterprise in the chemical industry. It is a continuous transformation platform for the scientific and technological achievements of the department of chemical engineering and the department of automation of tsinghua university. The company is committed to empowering industrial big data technology, industrial intelligent control technology, 5G technology, and AI technology. It can help chemical industry parks and chemical enterprises to help the construction of new infrastructure and industrial Internet in the chemical industry, and promote the intelligent transformation and upgrading of chemical enterprises and the construction of intelligent factories.
GritWorld
Series B in 2022
GritWorld GmbH specializes in designing and developing advanced real-time graphics and large-scale 3D reconstruction software solutions. Founded in 2015 and headquartered in Frankfurt am Main, Germany, with additional offices in Shanghai and Guangzhou, the company offers a range of products including GritRena, which reconstructs 3D models from 2D photos, GritVis, a suite of cinematic tools for game engines, and SmartCity, a platform for visualizing urban information in 3D. GritWorld aims to enhance the efficiency and quality of real-time data simulation and visualization across various industries, including entertainment, urban management, and industrial applications. By facilitating the transition from standard data formats to high-quality graphical representations, GritWorld aids in the digital transformation of businesses, promoting advancements in computer graphics, virtual reality, and augmented reality technologies.
ShadowBot
Series C in 2022
ShadowBot specializes in creating software robots that automate repetitive online tasks. Its technology simulates human operations, allowing the robot to perform actions such as mouse clicks, keyboard input, and information retrieval across various applications. By integrating this automation into business processes, ShadowBot enables enterprises to enhance their efficiency and productivity, ultimately streamlining operations and reducing the time spent on routine tasks.
Yingsheng Biology
Series C in 2022
Yingsheng Biotechnology Co., Ltd., established in 2009, specializes in the development and production of in vitro diagnostic reagents and medical equipment focused on maternal and child health, neonatal genetic diseases, and metabolic disorders. The company offers a diverse range of products, including 45 innovative genetic metabolic disease screening reagents, deaf genetic testing kits, and HLA-B27 detection kits. These products aim to facilitate early detection of genetic conditions and birth defects, promoting timely intervention and disease prevention. Yingsheng Bio utilizes advanced molecular diagnostic techniques and sophisticated detection systems, contributing significantly to the fields of human genetics and public health.
JD Property
Series B in 2022
JD Property is an infrastructure asset manager that specializes in logistics real estate development, leasing, and management. The company offers a range of services, including comprehensive property services and asset management. It focuses on developing modern standard warehouses and integrated intelligent industrial parks, along with data centers and photovoltaic new energy solutions. Through its investment development and diversified value-added services, JD Property aims to provide comprehensive infrastructure construction and operational solutions for various industries.
FAIR
Series B in 2022
FAIR is a collaborative robot company that has research and development and manufacturing capabilities for robot core components and complete machine systems such as robot controllers, precision reducers, and servo systems.
Enkris Semiconductors
Series B in 2022
Enkris Semiconductors specializes in the development of high-quality gallium nitride (GaN) epitaxial wafers tailored for power electronics and micro-display applications. The company offers a range of material solutions, including GaN-on-Si, GaN-on-SiC, GaN-on-Sapphire, and GaN-on-GaN, which are designed to support the next generation of RF devices and micro-LED technology. By utilizing CMOS-compatible technology, Enkris Semiconductors aims to produce reliable and cost-effective GaN materials, allowing businesses in power electronics and micro-display sectors to enhance their product performance and efficiency. Through its focus on innovation and quality, the company is positioned to meet the growing demands of these advanced technological fields.
Qmai.cn
Series C in 2022
Qmai.cn is an enterprise services company based in Hefei that specializes in developing a business management platform tailored for retailers and chain store operators. The platform offers a range of operational solutions, including enterprise smart retail features, digital store operations, and payment acquiring services. By providing these tools, Qmai.cn enables retailers to enhance user connections and streamline their operations through digitalization.
Fenbeitong
Series C in 2022
Fenbeitong is a corporate wallet application designed to streamline the management of corporate expenditures. The platform enables users to oversee, pay, and receive reimbursements for various business-related expenses, such as travel and procurement. By implementing intelligent control rules and reminder measures, Fenbeitong assists enterprises in significantly reducing costs associated with public consumption. Its credit monthly payment and unified invoice consumption model provide employees with a convenient way to manage expenditures without the burden of reimbursement processes, thus enhancing operational efficiency. Overall, Fenbeitong focuses on improving the financial management of corporate spending while facilitating a more efficient workflow for businesses.
Deep View Technology
Series B in 2022
Deep View Technology specializes in motion capture and the development of augmented reality (AR) and virtual reality (VR) applications. The company focuses on research and development related to three-dimensional computer vision algorithms. Utilizing wearable devices, Deep View Technology's services enable the identification of body part gestures, allowing clients to capture human postures in real time. This innovative approach enhances interactive experiences in virtual environments.
Bluepha
Series B in 2022
Bluepha is a company that specializes in synthetic biotechnology, integrating bioengineering and data science to create innovative bio-based products. It focuses on the research and development of microbial manufacturing and material innovation, applying synthetic biology to optimize cells for diverse applications, including energy and pharmaceuticals. Bluepha aims to deliver value across various industries such as consumer goods, healthcare, specialty chemicals, agriculture, and electronics. By leveraging bio-engineering techniques, the company enables clients to assemble products from engineered cell materials, advancing the field of bio-manufacturing.
UWinTech
Series C in 2022
UWinTech is a comprehensive provider of IT operations and maintenance solutions, established in 2015 and headquartered in Shenzhen, China. The company specializes in application management services that encompass continuous delivery, continuous deployment, operation automation, and application monitoring. Its product offerings include EasyCMDB, Easydevops, Easyobserve, EasyMAbuilder, and Easyautoops. By delivering these integrated services, UWinTech aims to assist enterprises in streamlining their IT operations, thereby reducing operational efforts and enhancing productivity.
Guoyi Quantum
Series C in 2021
Guoyi Quantum is a company that uses quantum precision measurement as its core technology to provide enterprises, governments, and research institutions around the world with core key devices represented by enhanced quantum sensors, scientific instruments and equipment for analysis and testing, and enable industry applications. Products and services such as core technology solutions. The company faces the fields of advanced materials, semiconductors, quantum science, life technology, medicine and clinical research, and is committed to helping customers promote the development of technology more efficiently and explore the future of mankind.
NASN Automotive Electronics
Series C in 2021
NASN Automotive Electronics Co., Ltd. is a manufacturer based in Shanghai, China, specializing in electronic chassis control products and autonomous driving technologies for the automotive market. The company offers a range of products, including the NBooster intelligent brake system, brushless electric steering EPS controller, and wire control systems. By focusing on research and development, production, and sales, NASN aims to provide advanced and comprehensive solutions that enhance vehicle safety and intelligence, catering to the growing demand for innovative automotive technologies in China.
Leadsynbio
Series C in 2021
Leadsynbio is a bio-manufacturing technology research and development company, focusing on bio-manufacturing of major chemical products, bio-process substitution in heavy-polluting industries, etc., providing users with bio-catalytic synthesis processes, enzyme product research and development, production, sales, and downstream companies with enzyme engineering , Technical service outsourcing and production service outsourcing of strain transformation and metabolic engineering.
Lingxing
Series C in 2021
Lingxing is a cross-border e-commerce SaaS service provider of ERP functional software products and solutions.
LePure Biotech
Series B in 2021
Lechun Biology is an enterprise engaged in disposable products and leak detection equipment in the biotechnology and pharmaceutical industries. The company develops and produces disposable biopharmaceutical process equipment and consumables. The products are used for the storage, transportation, filling and leak detection of various samples in biosimilars, vaccines and other biopharmaceutical processes. The core product is a disposable storage bag. Recently completed B+ round of financing. This round of financing will be mainly used for the development of a number of innovative new products, the establishment of a US R&D center, the integration of the upstream industrial chain, the securing of the supply chain, and the expansion of the R&D market operation team at home and abroad.
DP Technology
Series B in 2021
DP Technology is a global leader in the "AI for Science" research paradigm, where AI learns scientific principles and data, then tackles key challenges in scientific research and industrial R&D. DP's commitment to interdisciplinary research has led to the creation of the DP "Particle Universe", an array of pre-trained large science models designed to bridge foundational research with practical industrial applications. DP's software suite includes the Bohrium® Scientific Research Space, Hermite® Computational Drug Design Platform, RiDYMO® Dynamics Platform, and Piloteye® Battery Design Automation Platform. Together, these platforms form a robust foundation for industrial innovation and an open ecosystem for AI in science, fostering advancements in key areas such as drug discovery, energy, material science, and information technology.
CertiK
Series B in 2021
CertiK, established in 2018, is a leading blockchain security company. Headquartered in New York with offices in Beijing, Seoul, and Seattle, it specializes in securing smart contracts and blockchain ecosystems. CertiK offers security audits, penetration testing, and custom formal verification services, utilizing AI technology to protect and monitor blockchain protocols and smart contracts in real-time. The company, founded by professors from Yale and Columbia Universities, aims to secure the web3 world by applying cutting-edge academic innovations to enterprise-level applications.
GritWorld
Series B in 2021
GritWorld GmbH specializes in designing and developing advanced real-time graphics and large-scale 3D reconstruction software solutions. Founded in 2015 and headquartered in Frankfurt am Main, Germany, with additional offices in Shanghai and Guangzhou, the company offers a range of products including GritRena, which reconstructs 3D models from 2D photos, GritVis, a suite of cinematic tools for game engines, and SmartCity, a platform for visualizing urban information in 3D. GritWorld aims to enhance the efficiency and quality of real-time data simulation and visualization across various industries, including entertainment, urban management, and industrial applications. By facilitating the transition from standard data formats to high-quality graphical representations, GritWorld aids in the digital transformation of businesses, promoting advancements in computer graphics, virtual reality, and augmented reality technologies.
Alluxio
Series C in 2021
Alluxio, Inc. is a provider of a memory-centric distributed storage system that facilitates unified data access across various applications and underlying storage systems. Founded in 2015 and based in Berkeley, California, the company emerged from an open-source project developed at UC Berkeley's AMPLab. Alluxio's platform enhances data orchestration, enabling analytics and machine learning operations in cloud environments by relocating data closer to compute resources. This architecture supports memory-speed access to files and objects, benefiting sectors such as financial services, retail, and telecommunications. The company has established a strategic collaboration with Intel to further advance its technology and offerings.
Js Designs
Series B in 2021
'xiaopiu', a product of Beijing Xueyun Ruichuang Technology Co., Ltd., is an online APP prototyping tool. You can enjoy a software-level smooth experience by opening a browser, cloud component library, interactive motion customization, and efficient and friendly operation. Your creativity is instantly presented. * Cloud resources, one-click reference: Users can refer to shared resources shared by others with one click, so that users can focus more on expressing their ideas and ideas, and avoid creating wheels repeatedly. * Quickly build interactive animation: After creating the state and modifying the component to the desired style, we will automatically generate the tween animation. The user can preview and adjust the animation at any time through the bottom timeline, which is quick and convenient. * Global architecture, free to master: multi-view panel lists all the pages of the project, users can quickly process and logically arrange the page, so that the entire project architecture is unobstructed.
Datacloak
Series B in 2021
Datacloak, Inc. is a Shenzhen-based company that specializes in developing a computing platform focused on data security and privacy protection. The firm offers solutions that enable enterprises to store, access, and share data securely, employing technologies that facilitate secure communication between devices and company networks. Datacloak's offerings include enterprise computing, cloud computing, and artificial intelligence, which together create software-defined adaptive computing environments. This technology supports a decentralized approach to data storage, management, and transmission, allowing organizations to enhance their operational capabilities by integrating private and hybrid cloud environments.
Agile Robots
Series C in 2021
Agile Robots AG is a German company, founded in 2018 and headquartered in Gilching, with an additional office in Beijing, China. The company specializes in developing advanced robotic solutions that integrate artificial intelligence to enhance manufacturing, medical assistance, and service robotics. Its core offerings include a lightweight robotic arm featuring seven degrees of freedom and a general-purpose robot controller, designed for versatility in various applications. Agile Robots also provides a sophisticated robot vision system and scalable robotics optimized for seamless integration of perception, intelligence, and actuation. These systems are equipped with ultra-sensitive joint torque sensors, enabling them to detect and respond to interactions with human users and their environments, effectively bridging the gap between artificial intelligence and the physical world.
VanMoof
Series C in 2021
VanMoof is a designer and developer of urban e-bikes, aimed at providing a convenient commuting solution for modern city-dwellers. Founded in 2008 and headquartered in Amsterdam, the company focuses on enabling users to travel efficiently and stylishly. VanMoof's e-bikes are equipped with advanced features such as antitheft systems, intelligent motors, and automatic electronic gear shifting, which enhance the commuting experience and promote sustainable transportation. By integrating technology into their designs, VanMoof aims to help users navigate urban environments more effectively.
Etern
Series B in 2021
Etern is developing small molecule drugs for protein liquid-liquid phase separation, using the LLPS platform for AI-enabled target discovery, high-throughput screening, and optimization. This could open new treatment strategies for major diseases.
CertiK
Series B in 2021
CertiK, established in 2018, is a leading blockchain security company. Headquartered in New York with offices in Beijing, Seoul, and Seattle, it specializes in securing smart contracts and blockchain ecosystems. CertiK offers security audits, penetration testing, and custom formal verification services, utilizing AI technology to protect and monitor blockchain protocols and smart contracts in real-time. The company, founded by professors from Yale and Columbia Universities, aims to secure the web3 world by applying cutting-edge academic innovations to enterprise-level applications.
Qmai.cn
Series B in 2021
Qmai.cn is an enterprise services company based in Hefei that specializes in developing a business management platform tailored for retailers and chain store operators. The platform offers a range of operational solutions, including enterprise smart retail features, digital store operations, and payment acquiring services. By providing these tools, Qmai.cn enables retailers to enhance user connections and streamline their operations through digitalization.
Hangzhou Stupa Network Technology
Series B in 2021
PerfMa (Hangzhou Bumma Network Technology Co., Ltd.) is committed to providing enterprises with comprehensive solutions in the field of performance optimization, and establishes a complete set of performance guarantee system from performance pressure measurement, monitoring, positioning to optimization to ensure that the application system is under rapid iteration. Code quality and stability. At the same time, it will improve the research and development efficiency, save resource costs, lower the recruitment threshold, enhance the overall technical strength, and help enterprises to develop at a high speed
Pulse Medical Technology
Series C in 2021
Pulse Medical Technology develops innovative technology for the diagnosis and optimal treatment of pan-vascular diseases.
Pulse
Series C in 2021
Pulse is a health care service provider that assess coronary physiology and biomechanics through innovative techniques.
MicroPort CRM
Series C in 2021
MicroPort CRM is a leading company in Cardiac Rhythm Management, headquartered in Clamart, France. As a subsidiary of MicroPort Scientific Corporation, it specializes in the development, manufacturing, and marketing of advanced medical devices for managing cardiac rhythm disorders and heart failure. The company's product portfolio includes cardiac pacemakers, implantable cardiac defibrillators, cardiac resynchronization systems, and ECG diagnostic solutions. With a strong focus on research and development, MicroPort CRM aims to provide innovative treatments for arrhythmias and heart failure, responding to the growing global demand for effective cardiac care solutions driven by an aging population. Manufacturing facilities are located in Clamart, France, Saluggia, Italy, Santo Domingo, Dominican Republic, and Shanghai, China.
Nobell Foods
Series B in 2021
Nobell Foods is a biotech company based in San Francisco, California, that specializes in developing and producing animal-based food substitutes using plant materials. Founded in 2016, the company aims to transform plants into bioreactors to generate protein, unlocking their potential to create innovative food alternatives. By focusing on plant-based solutions, Nobell Foods seeks to provide sustainable options that can replace traditional animal products, contributing to a more environmentally friendly food system.
Nature's Fynd
Series C in 2021
Nature's Fynd is a Chicago-based food company that specializes in producing a unique protein derived from a microbe found in geothermal springs. Founded in 2012 and originally known as Sustainable Bioproducts, Inc., the company focuses on creating sustainable food options that benefit both consumers and the environment. Utilizing innovative fermentation technology, Nature's Fynd is able to cultivate protein using significantly less land and water compared to conventional agricultural methods. The company also operates an additional office in Bozeman, Montana, and aims to contribute to a more sustainable food system through its revolutionary approach to protein production.
VirtAI Tech
Series B in 2021
VirtAI Tech specializes in the development of innovative GPU resource pooling technology and AI computing power distribution systems designed for data centers. Its flagship product, the Orion AI computing platform, enables customers to create datacenter-class AI accelerator resource pools, allowing user applications to seamlessly share and utilize AI accelerators across servers without modification. This technology significantly enhances resource utilization and simplifies the deployment of applications. By focusing on advanced virtual graphics processing units, VirtAI Tech ensures that computations performed on physical GPUs can be executed with minimal performance loss, thereby optimizing the efficiency of computing power within data centers. The platform has attracted interest from various artificial intelligence, Internet, and public cloud companies.
Qitan Technology
Series B in 2021
Chengdu Qitan Technology Co., Ltd. specializes in the development and manufacture of advanced gene sequencing instruments utilizing nanopore technology. Founded in 2016 and based in Chengdu, China, the company offers a fourth generation gene sequencer that enables single-molecule sequencing with long read lengths and real-time output. This innovative technology is designed to serve various sectors, including biopharmaceuticals, healthcare, and agriculture, facilitating applications such as immunophenotyping, pathogen detection, analysis of intestinal flora, and tumor genome detection. Qitan Tech's solutions are notable for their cost-effectiveness and simplicity, as they do not require complicated library preparation, thus enhancing the accessibility of gene sequencing for cutting-edge biological research and clinical diagnostics.
Facily
Series C in 2021
Facily is a social commerce marketplace operating in Latin America, designed to cater to low-ticket items and provide competitive prices alongside efficient logistics for lower-income neighborhoods. The platform emphasizes community engagement by facilitating group buying, allowing users to purchase products collectively while enjoying interactive experiences such as games and quizzes. By harnessing local leaders and influencers, Facily enhances its appeal and promotes a sense of community among buyers. Users can also earn rewards by inviting friends, making the shopping experience not only economical but also enjoyable and socially engaging.
Lingxing
Series B in 2021
Lingxing is a cross-border e-commerce SaaS service provider of ERP functional software products and solutions.
SmartAHC
Series B in 2021
SmartAHC, incubated by Nanyang Technological University, focuses on intelligent farming solutions specifically for livestock management. The company develops innovative pig wearables and a tracking system that automatically and remotely monitor the health and ovulation periods of pigs. This technology allows farmers to reduce labor costs while enhancing the care and management of their livestock. By providing tools for breeding, inventory counting, growth monitoring, and behavioral analysis, SmartAHC aims to improve the overall efficiency of farming operations. The company has garnered support from a range of prominent investors, reflecting its potential impact on the agriculture sector.
Jianjia Robot
Series C in 2021
Jianjia Robot develops a hard tissue surgical robot platform promoting technological progress in the field of surgery at home and abroad. Jianjia Robot's orthopedic joint surgical robot, ARTHROBOT, can cover both hip and knee joints, breaking the long-term monopoly of imported surgical robots in this field.
Star Charge
Series B in 2021
Star Charge specializes in the development and manufacturing of charging equipment specifically for new energy vehicles. The company serves a global clientele by providing comprehensive charging infrastructures, platforms, and data operations, leveraging Internet of Things technologies. Star Charge's offerings encompass various aspects of electric vehicle support, including vehicle sales, private and public charging solutions, and financial services. By focusing on these areas, the company aims to enhance energy efficiency, facilitate structural adjustments in energy utilization, promote energy conservation, and mitigate pollution emissions.
RoboticPlus.AI
Series B in 2021
RoboticPlus.AI is a robotics company that focuses on advancing architectural technology by delivering intelligent robotic solutions tailored for the construction sector. It specializes in developing robotics technology that addresses the demands of mass customization within the industry. The company's products integrate design, computer science, artificial intelligence, and industrial manufacturing to enhance operational efficiency. By employing intelligent programming, digital design, and human-computer interaction, RoboticPlus.AI's robots enable customers to improve work efficiency and reduce labor costs, thereby transforming traditional construction practices.
Hetao101
Series C in 2021
Hetao101, also known as Walnut Coding, is a Beijing-based children's edtech company that focuses on providing programming education for children aged four to twelve. Founded in 2017, the company offers an AI-driven online platform and smart products designed to enhance children's logical thinking and programming skills. With a team of over 400 tutors, Hetao101 develops a specialized curriculum aligned with the Computer Science Teachers Association (CSTA) teaching standards. This curriculum emphasizes programming skill development, aiming to prepare students for higher education and foster an interest in computer science.
Bioheng
Series B in 2021
BioHeng is a clinical biopharmaceutical and biotechnology Company focuses on novel immunotherapy and next-generation gene therapy development for treating cancers and various diseases. Founded in 2017, Bioheng has established a high standard GMP grade clinical translational center, and is leading in the field of cell engineering, proliferation and clinical applications. Particularly, Bioheng owns several cutting-edge patents plus extensive industry experience, and has built a complete, closed and automated production system in compliance with regulatory guidelines. In 2018, Bioheng has successfully raised tens of millions of RMB seeding fund from Simcere Pharmaceutical Group, aiming to accelerate the development of immunotherapy via integrating resources from both parties. Bioheng is dedicated to develop safer, effective and less expensive cell therapy drugs to benefit more patients.
XAG
Series C in 2021
XAG Co., Ltd., established in 2007 and headquartered in Guangzhou, China, specializes in the design and manufacture of drones, robots, autonomous driving solutions, and AI-based equipment tailored for the agricultural industry. The company's product portfolio includes unmanned aerial vehicles (UAVs) for recreational and commercial use, ranging from hobbyist model aircraft to large-scale professional UAVs for various applications such as aerial imaging, monitoring, lifting, and logistics. XAG's offerings also extend to commercial and industrial products and services, which are employed in low-altitude airspace logistics, police and medical assistance, fire prevention, geological prospecting, surveying, and arctic expeditions.
Fenbeitong
Series C in 2021
Fenbeitong is a corporate wallet application designed to streamline the management of corporate expenditures. The platform enables users to oversee, pay, and receive reimbursements for various business-related expenses, such as travel and procurement. By implementing intelligent control rules and reminder measures, Fenbeitong assists enterprises in significantly reducing costs associated with public consumption. Its credit monthly payment and unified invoice consumption model provide employees with a convenient way to manage expenditures without the burden of reimbursement processes, thus enhancing operational efficiency. Overall, Fenbeitong focuses on improving the financial management of corporate spending while facilitating a more efficient workflow for businesses.
Bluepha
Series B in 2021
Bluepha is a company that specializes in synthetic biotechnology, integrating bioengineering and data science to create innovative bio-based products. It focuses on the research and development of microbial manufacturing and material innovation, applying synthetic biology to optimize cells for diverse applications, including energy and pharmaceuticals. Bluepha aims to deliver value across various industries such as consumer goods, healthcare, specialty chemicals, agriculture, and electronics. By leveraging bio-engineering techniques, the company enables clients to assemble products from engineered cell materials, advancing the field of bio-manufacturing.
LakeShore Biopharma
Series B in 2021
Yisheng Biopharma Co., Ltd. is a biopharmaceutical company focused on the research, development, manufacturing, and marketing of immuno-oncology products and vaccines. Founded in 2002 and headquartered in Beijing, the company operates in China, the United States, Cambodia, and Singapore. Yisheng Biopharma utilizes its novel PIKA immunomodulating technology to enhance immune responses against cancers and infectious diseases. Key products under development include YS-ON-001, an investigational therapy aimed at treating advanced solid tumors, as well as YS-HBV-001, a vaccine for hepatitis B, and a PIKA-based rabies vaccine designed for rapid protection against rabies infection. The company's innovative approach targets multiple immune pathways to improve treatment outcomes.
Cryofocus Biotech
Series B in 2021
Cryofocus Biotech is a Shanghai-based cryoablation device manufacturer, focusing on the application of cryogenic technology in the field of cardiovascular interventional therapy.
Exegenesis Bio
Series B in 2021
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.
Agile Robots
Series B in 2021
Agile Robots AG is a German company, founded in 2018 and headquartered in Gilching, with an additional office in Beijing, China. The company specializes in developing advanced robotic solutions that integrate artificial intelligence to enhance manufacturing, medical assistance, and service robotics. Its core offerings include a lightweight robotic arm featuring seven degrees of freedom and a general-purpose robot controller, designed for versatility in various applications. Agile Robots also provides a sophisticated robot vision system and scalable robotics optimized for seamless integration of perception, intelligence, and actuation. These systems are equipped with ultra-sensitive joint torque sensors, enabling them to detect and respond to interactions with human users and their environments, effectively bridging the gap between artificial intelligence and the physical world.
Ark Biosciences
Series C in 2021
Ark Biosciences Inc. is a biopharmaceutical company based in Shanghai, China, focused on discovering and developing therapeutics for unmet medical needs, particularly in respiratory viral infections and viral hepatitis. Founded in 2013, the company is dedicated to addressing global health challenges with its innovative products, which include AK0701 for chronic obstructive pulmonary disease, AK0529 for respiratory syncytial virus, AK0612 for influenza, and AK0705 and AK0706 for hepatitis B. Ark Biosciences aims to establish itself as a leader in antiviral drug development through a commitment to scientific excellence and innovation.
Targeting One
Series B in 2021
Beijing Targeting One Technology Co., Ltd. specializes in the development and production of biomedical instruments and consumables, focusing on in vitro diagnostic reagents for precision medicine, health management, and life science research. Established in 2015 and based in Beijing, the company offers a range of products including sample preparation apparatus, biochip readers, digital PCR supplies, and genetic testing kits. Its digital PCR solutions play a crucial role in medical diagnostics, with applications in transplant rejection monitoring, targeted sequencing, tumor liquid biopsy, and non-invasive prenatal screening. Targeting One aims to enhance gene testing and precision medicine through its innovative technologies and comprehensive offerings.
Core Medical Technology
Series B in 2021
Core Medical Technology is a technology enterprise mainly engaged in the research, production, development, and sales of implantable left ventricular assist devices, extracorporeal ventricular assist devices, percutaneous interventional ventricular assist devices, and equipment. The company was founded in 2016 and is based in Shenzhen, China.
ImmVira
Series C in 2020
Immvira, founded in Shenzhen, China, in May 2015 by a group of prominent professors from various universities, is focused on developing biopharmaceutical technology in the field of immunotherapy. The company specializes in creating oncolytic viruses and vector-type approaches aimed at treating cancer. Its primary product is a genetically engineered Oncolytic Herpes Simplex Virus, which is designed to target metastatic tumors or tumors that are difficult to access by direct injection. By leveraging this innovative technology, Immvira aims to provide more effective treatment solutions for patients suffering from cancer.
EMQ Technologies
Series B in 2020
EMQ is an open-source IoT data infrastructure software provider, delivering the world's leading cloud-native MQTT-based IoT messaging platform and streaming database, providing a one-stop cloud-native solution for real-time IoT data connection, movement, processing and analytics, from edge to cloud to multi-cloud. As a global organization, EMQ located its R&D center in Stockholm, Sweden, and has 10+ offices throughout the Americas, Europe, and the Asia-Pacific region. The flagship product EMQX is adopted by more than 20,000 enterprise users from over 50 countries, connecting more than 100 million IoT devices worldwide. Trusted by over 300 customers in business-critical production environment, EMQ powers the future-proof IoT solutions and enterprise digital transformation.
Creech Medical Technology Development
Series C in 2020
Creativity (Beijing) Medical Technology Development Co., Ltd. is a leading minimally invasive interventional delivery system product full solution provider. Committed to cooperating with top experts at home and abroad in the field of minimally invasive intervention, and cooperating with internationally renowned raw material manufacturers to jointly develop, produce and sell leading products. Provide doctors with differentiated diagnosis and treatment tools, relieve patients' pain and reduce medical burden.
Grand Voyage Holdings
Series B in 2020
Grand Voyage Holdings is a lighting device producer and retailer. They serve traditional light source lamps and LED lamps with analog or digital control products. They focus on improving the livability and effectiveness of indoor and outdoor environments.
Horizon Robotics
Series C in 2020
Horizon Robotics is a prominent provider of advanced driver assistance systems (ADAS) and autonomous driving solutions specifically designed for passenger vehicles. The company develops proprietary software and hardware that integrate advanced algorithms and specialized processing capabilities. These technologies form the foundation for enhanced driving automation, aiming to improve both safety and the overall experience for drivers and passengers. By focusing on innovative solutions, Horizon Robotics plays a key role in the evolution of assisted and autonomous driving.
Yonghui Fresh Food
Series B in 2020
Yonghui Fresh Food operates as a supply chain integration platform specializing in fresh food and agricultural products. The company focuses on delivering timely supply chain services to a diverse range of customers, addressing their various purchasing needs. By streamlining food management and supply chain processes, Yonghui Fresh Food supports enterprises within the food industry, ensuring efficient access to fresh products.
Zilliz
Series B in 2020
Zilliz is a prominent vector database company based in San Francisco, California, founded in 2016. It specializes in developing advanced data processing platforms that leverage artificial intelligence and big data technologies. Zilliz is known for Milvus, an open-source vector database designed to facilitate the creation of AI and machine learning applications. By simplifying complex data infrastructure management, the company aims to enable organizations to harness the advantages of AI for a variety of applications, including computer vision, natural language processing, recommendation systems, and more. Zilliz supports over 1,000 organizations globally, helping them unlock insights from unstructured data while improving query performance through GPU hardware acceleration. Its investor backing includes notable firms such as Hillhouse Capital and Temasek's Pavilion Capital, underscoring its position in the AI and data management sectors.
Yingsheng Biology
Series B in 2020
Yingsheng Biotechnology Co., Ltd., established in 2009, specializes in the development and production of in vitro diagnostic reagents and medical equipment focused on maternal and child health, neonatal genetic diseases, and metabolic disorders. The company offers a diverse range of products, including 45 innovative genetic metabolic disease screening reagents, deaf genetic testing kits, and HLA-B27 detection kits. These products aim to facilitate early detection of genetic conditions and birth defects, promoting timely intervention and disease prevention. Yingsheng Bio utilizes advanced molecular diagnostic techniques and sophisticated detection systems, contributing significantly to the fields of human genetics and public health.
Hocermed
Series C in 2020
Hocermed is a provider of energy platforms for invasive surgery. They has established research and development bases. They creates a comprehensive system that supports research and development, quality control, production, sales, and service. They supplies products with minimally invasive surgical solutions to healthcare professionals. They also invasive surgical energy devices. They provides surgical products and services to surgeons.
BioNova Pharma
Series B in 2020
BioNova Pharma biopharmaceutical company that develops and commercializes innovative medicines for cancer and other life-threatening diseases. The company is expanding company with a strong pipeline based on in-house R&D initiatives, partnerships with, and purchases from partners with cutting-edge technology. The goal of BioNova is to close the gap between the high unmet medical needs and the dearth of innovative medicines by developing an innovative R&D platform with a substantial pipeline to address multiple disease areas.
Hemu (China) Biological Engineering
Series B in 2020
Hemu (China) Biological Engineering is a Chinese blood vessel intervention medical equipment firm.
Zhaoke Ophthalmology Pharmaceutical
Series B in 2020
Zhaoke Ophthalmology Pharmaceutical is a Pharmaceutical platform.
WeMed Medical
Series C in 2020
WeMed is a developer of digital angiography machines designed for use in the clinical fields of radiology and cardiology. The company focuses on enhancing department operations and providing training for medical professionals. Additionally, WeMed implements an international strategy for product research and development, ensuring that its offerings are continuously optimized and upgraded to meet the evolving needs of healthcare providers.
Paraview Software
Series C in 2020
Paraview Software is an enterprise-level IT management solution provider that specializes in serving digital enterprises. The company offers a range of services, including identity security solutions, enterprise cybersecurity infrastructure, and big data and analytics management. Additionally, Paraview Software provides digital transformation services to help organizations across various industries enhance their digitalization efforts and improve operational efficiency. The company's notable products include the ParaSecure OSC operation and maintenance security management software and the ParaSecure AAC security log management system software.
Biren Technology
Series B in 2020
Biren Technology is a high-tech startup specializing in the design and development of intelligent processors tailored for GPU and DSA computation architectures. The company focuses on creating integrated software and hardware platforms that support intelligent computing applications, including cloud computing, artificial intelligence training, graphics rendering, and high-performance general-purpose computing. With a dedicated team of industry experts and elite engineers, Biren Technology aims to deliver versatile computing solutions that blend general computing capabilities with specific applications. Its research division is committed to advancing key technologies in intelligent computing systems, emphasizing new architectures and advanced compilation techniques, thereby facilitating technological breakthroughs in various high-tech sectors.
JD.com
Series B in 2020
JD.com, Inc., based in Beijing, is a leading e-commerce company in China, operating through its subsidiaries. It offers a wide array of products, from electronics and apparel to food and healthcare items, through its website and mobile apps. JD.com is notable for its extensive logistics network, JD Logistics, which provides efficient and reliable delivery services. The company also operates JD Health, a prominent online healthcare platform offering pharmaceuticals, medical supplies, and online consultations. JD.com's unique selling proposition lies in its self-operated logistics network, ensuring speedy and reliable delivery, and its commitment to providing authentic products. As of 2022, JD.com's gross merchandise volume (GMV) was comparable to Pinduoduo's, but still lower than Alibaba's.
BrosMed
Series C in 2020
BrosMed is a company that specializes in interventional vascular therapy services and the development of medical devices aimed at enhancing procedural outcomes for healthcare professionals. The company's product offerings include a series of interventional cardiovascular and endovascular catheters, which are utilized by cardiologists, radiologists, and vascular surgeons during angioplasty procedures and other minimally invasive interventions. By providing advanced medical devices, BrosMed enables clinicians to expand treatment options available to patients, ultimately contributing to improved patient outcomes while also reducing costs.
Antengene
Series C in 2020
Antengene Corporation is a biopharmaceutical company based in Shanghai, China, founded in 2016, that specializes in the development of innovative therapies for cancer treatment. The company's portfolio includes ATG-010 (selinexor), targeting hematologic malignancies such as multiple myeloma, and ATG-008 (onatasertib), an mTOR kinase inhibitor aimed at treating advanced solid tumors and hematological malignancies. Antengene's pipeline features several investigational products, including ATG-016 (eltanexor), ATG-527 (verdinexor), and ATG-019, along with pre-clinical candidates like ATG-101, a bi-specific antibody, and ATG-012, a KRAS G12C inhibitor. The company is committed to addressing unmet medical needs in Asia through its focus on the discovery, development, and commercialization of first-in-class therapeutics for various types of cancer.
Xpeng Motors
Series C in 2020
Xpeng Motors is a Chinese electric vehicle and technology company that specializes in the design and manufacture of smart cars. The company emphasizes local market needs and prioritizes consumer experience, integrating advanced autonomous driving features and internet-connected technologies into its vehicles. This approach aims to enhance the overall functionality and appeal of their cars, making them more than just traditional vehicles. Additionally, Xpeng Motors has a subsidiary, Xpeng Robotics, which focuses on developing smart robots as part of its broader mobility ecosystem.
Narwal Robotics
Series C in 2020
Narwal Robotics focus on design, development, and production of intelligent cleaning robots.
Volcan Craft
Series B in 2020
Volcan Craft, also known as Shanghai Kaishan Wine Co., Ltd., is a liquor brand established in 2017 and headquartered in Shanghai, China. The company focuses on producing and selling a variety of alcoholic beverages, catering primarily to the tastes of young consumers. Volcan Craft employs a hybrid business model that combines both online and offline sales channels to enhance accessibility and engagement with its target market. Through its innovative approach, the brand aims to establish a strong presence in the competitive liquor industry.
Baijia Food
Series B in 2020
Baijia Food specializes in the research and development, manufacturing, and marketing of healthy convenience foods and compound condiments. The company offers a diverse range of products, including non-fried instant noodles, instant vermicelli, instant rice noodles, self-heating food, and self-cooking noodles. Additionally, Baijia Food provides self-heating hot pots and rice, alongside Sichuan flavor compound seasonings, allowing customers to enjoy flavorful meals in a matter of minutes.
Everest Medicines
Series C in 2020
Everest Medicines Limited is a clinical-stage biopharmaceutical company based in Shanghai, China, founded in 2017. The company focuses on licensing, developing, and commercializing innovative therapies to meet critical unmet medical needs in Greater China and other Asia Pacific markets. Its diverse portfolio includes eight clinical-stage drug candidates aimed at treating various conditions such as oncology, immunology, cardio-renal diseases, and infectious diseases. Everest Medicines aims to partner with innovative global companies to bring transformative pharmaceutical solutions to the Emerging Market, leveraging its expertise in clinical development, regulatory affairs, and business operations. The company's pipeline features several notable candidates, including Nefecon, EVER001, PTX-COVID19-B, and Eravacycline, among others.
Genor BioPharma
Series B in 2020
Genor BioPharma Co., Ltd. is a biopharmaceutical company based in Shanghai, China, founded in 2007. It specializes in the development and commercialization of therapeutic monoclonal antibodies (mAbs) and Fc-fusion protein drugs, focusing primarily on oncology, autoimmune diseases, and metabolic disorders. The company aims to address significant unmet medical needs through its pipeline, which includes more than ten products, with several already in clinical development. Notable candidates include GB491, an oral CDK4/6 inhibitor; GB221, a novel HER2 mAb; geptanolimab (GB226); and GB242, an infliximab biosimilar. Genor BioPharma also collaborates strategically with Ascentage Pharma to enhance its research and development efforts.
Coalition
Series C in 2020
Coalition, Inc. is an insurance provider based in San Francisco, California, specializing in cyber risk management. Founded in 2017, the company offers a blend of comprehensive insurance coverage and proactive cybersecurity tools tailored for various industries, including healthcare, retail, technology, and more. Coalition's Active Risk Platform equips businesses with automated security alerts, threat intelligence, and expert guidance to enhance their resilience against cyber threats. By integrating risk assessment, security protection, and response capabilities, Coalition enables organizations to effectively mitigate and prevent potential cyber-attacks and associated losses. The company serves clients in the United States and Canada while providing its security solutions globally, supported by prominent global insurers.
Suzhou Ribo Life Science
Series C in 2020
Suzhou Ribo Life Science Co., Ltd. specializes in the development of nucleic acid drugs utilizing RNA interference (RNAi) technology, with a particular focus on treating liver diseases. Founded in 2007 and based in Kunshan, China, the company engages in various aspects of drug development, including drug discovery, siRNA design and screening, chemical modification, delivery technology, pharmacodynamics and pharmacokinetics studies, safety evaluation, and clinical trials. Suzhou Ribo Life Science offers siRNA therapeutics targeting conditions such as Hepatitis B, breast carcinoma, liver fibrosis, liver carcinoma, and HIV. The company has established a strategic partnership with Quark Pharmaceuticals, Inc. to enhance its research and development capabilities.
Tongyu
Series B in 2020
Shanghai Tongyu Information Technology Co., Ltd. specializes in providing financial derivatives trading solutions, established in 2016 and located in Shanghai, China. The company's platform addresses the infrastructure needs of the financial derivatives market in China by supporting traders with comprehensive tools for front, middle, and back-end trading. Tongyu offers critical services such as market data, pricing, risk control technical support, as well as liquidation and delivery tools, thereby enhancing the trading experience for financial derivatives traders.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.